Detail Information of Exogenous Modulation

General Information of Drug Transporter (DT)
DT ID	DTD0258 Transporter Info
Gene Name	SLC2A3
Transporter Name	Glucose transporter type 3, brain
Gene ID	6515
UniProt ID	P11169

Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM)
Mycotoxins
Aflatoxin B1	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Aflatoxin B1 results in decreased methylation of SLC2A3 3' UTR			[65]
Regulation Mechanism				Transcription Factor Info
DT Modulation2	Aflatoxin B1 results in decreased methylation of SLC2A3 intron			[65]
Regulation Mechanism				Transcription Factor Info
Biotoxin
yessotoxin	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	yessotoxin analog results in increased expression of SLC2A3 mRNA			[54]
Regulation Mechanism				Transcription Factor Info
Approved Drug
Bevacizumab	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Bevacizumab induces the transportation of Glucose by SLC2A3			[1]
Affected Drug/Substrate	Glucose	Modulation Type	Inducer
Oxaliplatin	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Oxaliplatin inhibits the expression of SLC2A3			[2]
Regulation Mechanism	via the inhibition of Transcriptional repressor protein YY1 (YY1)			Transcription Factor Info
Cell System	Human colon carcinoma isolates
Raloxifene Hydrochloride	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Raloxifene Hydrochloride affects the expression of SLC2A3			[3]
Chlorpromazine	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Chlorpromazine inhibits the expression of SLC2A3			[4]
Clozapine	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Clozapine inhibits the expression of SLC2A3			[4]
Flecainide	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Flecainide inhibits the expression of SLC2A3			[4]
Pentamidine	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Pentamidine inhibits the expression of SLC2A3			[4]
Sotalol	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Sotalol increases the expression of SLC2A3			[4]
Thioridazine	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Thioridazine inhibits the expression of SLC2A3			[4]
Vandetanib	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Vandetanib increases the expression of SLC2A3			[5]
Tretinoin	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Tretinoin inhibits the expression of SLC2A3			[6]
Gemcitabine	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Gemcitabine increases the expression of SLC2A3			[7]
Acetaminophen	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Acetaminophen inhibits the expression of SLC2A3			[8]
DT Modulation2	Acetaminophen results in increased expression of SLC2A3 mRNA			[63]
Regulation Mechanism				Transcription Factor Info
Citalopram	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Citalopram inhibits the expression of SLC2A3			[9]
Doxepin	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Doxepin inhibits the expression of SLC2A3			[9]
Bortezomib	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Bortezomib increases the expression of SLC2A3			[10]
Calcitriol	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Calcitriol increases the expression of SLC2A3			[11]
Testosterone	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Testosterone increases the expression of SLC2A3			[11]
Ampicillin	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Ampicillin increases the expression of SLC2A3			[12]
Niclosamide	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Niclosamide inhibits the expression of SLC2A3			[13]
Zidovudine	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Zidovudine inhibits the expression of SLC2A3			[15]
Methotrexate	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Methotrexate inhibits the expression of SLC2A3			[16]
Caffeine	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Caffeine increases the expression of SLC2A3			[17]
Carbamazepine	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Carbamazepine affects the expression of SLC2A3			[18]
Panobinostat	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Panobinostat increases the expression of SLC2A3			[19]
Vorinostat	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Vorinostat increases the expression of SLC2A3			[19]
Cisplatin	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Cisplatin increases the expression of SLC2A3			[20]
Urethane	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Urethane inhibits the expression of SLC2A3			[21]
Doxorubicin	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Doxorubicin inhibits the expression of SLC2A3			[22]
Avobenzone	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Avobenzone increases the expression of SLC2A3			[23]
Cannabidiol	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Cannabidiol increases the expression of SLC2A3			[24]
Sunitinib	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Sunitinib increases the expression of SLC2A3			[25]
Clomipramine	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Clomipramine inhibits the expression of SLC2A3			[8]
Amitriptyline	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Amitriptyline inhibits the expression of SLC2A3			[9]
Fluoxetine	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Fluoxetine inhibits the expression of SLC2A3			[9]
Imipramine	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Imipramine inhibits the expression of SLC2A3			[9]
Ketoconazole	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Ketoconazole inhibits the expression of SLC2A3			[9]
Loratadine	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Loratadine inhibits the expression of SLC2A3			[9]
Quinidine	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Quinidine inhibits the expression of SLC2A3			[9]
Sertraline	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Sertraline inhibits the expression of SLC2A3			[9]
Tamoxifen	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Tamoxifen inhibits the expression of SLC2A3			[9]
Amiodarone	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Amiodarone inhibits the expression of SLC2A3			[27]
Cyclosporine	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Cyclosporine inhibits the expression of SLC2A3			[28]
Arsenic Trioxide	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Arsenic Trioxide increases the expression of SLC2A3			[29]
Valproic Acid	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Valproic Acid increases the expression of SLC2A3			[30]
Estradiol	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Estradiol increases the expression of SLC2A3			[31]
Regulation Mechanism	via enhancement of Cyclic AMP-responsive element-binding protein 1 (CREB1)			Transcription Factor Info
Affected Drug/Substrate	Glucose	Modulation Type	Inducer
Cell System	Human neuroblastoma cells (SH-SY5Y)
Drug Marketed but not Approved by US FDA
Demecolcine	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Demecolcine increases the expression of SLC2A3			[14]
Rotenone	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Rotenone inhibits the expression of SLC2A3			[26]
Drug in Phase 3 Trial
torcetrapib	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	torcetrapib increases the expression of SLC2A3			[41]
Sulforafan	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Sulforafan increases the expression of SLC2A3			[47]
Triclosan	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Triclosan inhibits the expression of SLC2A3			[53]
Epigallocatechin gallate	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Epigallocatechin gallate increases the expression of SLC2A3			[58]
Drug in Phase 2 Trial
MS-275	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	MS-275 increases the expression of SLC2A3			[19]
Bisphenol A	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Bisphenol A affects the expression of SLC2A3			[56]
Drug in Phase 1 Trial
Chlorcyclizine	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Chlorcyclizine inhibits the expression of SLC2A3			[4]
WSM-3978G	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	WSM-3978G inhibits the expression of SLC2A3			[4]
Dinitrochlorobenzene	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Dinitrochlorobenzene inhibits the expression of SLC2A3			[35]
Quercetin	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Quercetin inhibits the expression of SLC2A3			[12]
Dihydrotestosterone	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Dihydrotestosterone increases the expression of SLC2A3			[51]
Sodium arsenite	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Sodium arsenite inhibits the expression of SLC2A3			[60]
Trichostatin A	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Trichostatin A increases the expression of SLC2A3			[19]
Drug in Preclinical Test
(+)-JQ1	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	(+)-JQ1 inhibits the expression of SLC2A3			[40]
Investigative Drug
Tributyltin	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Tributyltin inhibits the expression of SLC2A3			[35]
Archazolid B	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Archazolid B increases the expression of SLC2A3			[43]
SB-431542	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	SB-431542 increases the expression of SLC2A3			[44]
Phenylmercuric Acetate	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Phenylmercuric Acetate increases the expression of SLC2A3			[19]
PP242	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	PP242 inhibits the expression of SLC2A3			[54]
Milchsaure	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Milchsaure affects the expression of SLC2A3			[55]
Patented Pharmaceutical Agent
Eugenol	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Eugenol increases the expression of SLC2A3			[34]
K-7174	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	K-7174 inhibits the expression of SLC2A3			[42]
GSK-J4	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	GSK-J4 increases the expression of SLC2A3			[50]
Natural Product
DT Modulation1	Caffeine affects the phosphorylation of SLC2A3 protein			[82]
Regulation Mechanism				Transcription Factor Info
Particulate Matter	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Particulate Matter increases the expression of SLC2A3			[38]
Tobacco Smoke Pollution	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Tobacco Smoke Pollution inhibits the expression of SLC2A3			[59]
Environmental toxicant
Resorcinol	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Resorcinol increases the expression of SLC2A3			[39]
Polychlorinated dibenzodioxin	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Polychlorinated dibenzodioxin inhibits the expression of SLC2A3			[12]
Lead	4 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	lead acetate results in increased abundance of Lead which results in decreased expression of SLC2A3 mRNA			[93]
Regulation Mechanism				Transcription Factor Info
DT Modulation2	lead acetate results in increased abundance of Lead which results in decreased expression of SLC2A3 protein			[93]
Regulation Mechanism				Transcription Factor Info
DT Modulation3	PPIF protein affects the reaction lead acetate results in increased abundance of Lead which results in decreased expression of SLC2A3 mRNA			[93]
Regulation Mechanism				Transcription Factor Info
DT Modulation4	PPIF protein affects the reaction lead acetate results in increased abundance of Lead which results in decreased expression of SLC2A3 protein			[93]
Regulation Mechanism				Transcription Factor Info
Acute Toxic Substance
trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride inhibits the expression of SLC2A3			[4]
Uranium	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Uranium affects the expression of SLC2A3			[32]
Nickel chloride	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Nickel chloride increases the expression of SLC2A3			[33]
Cadmium	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Cadmium inhibits the expression of SLC2A3			[36]
Thimerosal	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Thimerosal inhibits the expression of SLC2A3			[48]
Formaldehyde	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Formaldehyde increases the expression of SLC2A3			[49]
Carcinogen
Benzo(a)pyrene	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Benzo(a)pyrene inhibits the expression of SLC2A3			[61]
Arsenic	3 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	sodium arsenate results in increased abundance of Arsenic which results in increased expression of SLC2A3 mRNA			[71]
Regulation Mechanism				Transcription Factor Info
DT Modulation2	sodium arsenite results in increased abundance of Arsenic co-treated with manganese chloride results in increased abundance of Manganese results in increased expression of SLC2A3 mRNA			[72]
Regulation Mechanism				Transcription Factor Info
DT Modulation3	sodium arsenite results in increased abundance of Arsenic which results in increased expression of SLC2A3 mRNA			[72]
Regulation Mechanism				Transcription Factor Info
Nickel	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Nickel results in increased expression of SLC2A3 mRNA			[96]
Regulation Mechanism				Transcription Factor Info
Health and Environmental Toxicant
Butyraldehyde	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Butyraldehyde inhibits the expression of SLC2A3			[45]
tris(1,3-dichloro-2-propyl)phosphate	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	tris(1,3-dichloro-2-propyl)phosphate inhibits the expression of SLC2A3			[46]
Diethylhexyl Phthalate	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Diethylhexyl Phthalate increases the expression of SLC2A3			[57]
Nanoparticle
Silver nanoparticle	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Silver nanoparticle increases the expression of SLC2A3			[52]
Chemical Compound
DT Modulation1	Flecainide results in increased expression of SLC2A3 mRNA			[8]
Regulation Mechanism				Transcription Factor Info
DT Modulation1	Tretinoin results in increased expression of SLC2A3 mRNA			[114]
Regulation Mechanism				Transcription Factor Info
DT Modulation1	Testosterone co-treated with Calcitriol results in increased expression of SLC2A3 mRNA			[11]
Regulation Mechanism				Transcription Factor Info
DT Modulation1	Testosterone co-treated with Calcitriol results in increased expression of SLC2A3 mRNA			[11]
Regulation Mechanism				Transcription Factor Info
DT Modulation1	Niclosamide results in increased expression of SLC2A3 mRNA			[98]
Regulation Mechanism				Transcription Factor Info
DT Modulation1	NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC2A3 mRNA			[48]
Regulation Mechanism				Transcription Factor Info
DT Modulation1	NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC2A3 mRNA			[48]
Regulation Mechanism				Transcription Factor Info
DT Modulation1	Rotenone results in increased expression of SLC2A3 protein			[109]
Regulation Mechanism				Transcription Factor Info
DT Modulation1	Tamoxifen affects the expression of SLC2A3 mRNA			[3]
Regulation Mechanism				Transcription Factor Info
DT Modulation1	NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC2A3 mRNA			[48]
Regulation Mechanism				Transcription Factor Info
DT Modulation1	Estradiol co-treated with TGFB1 protein results in decreased expression of SLC2A3 mRNA			[90]
Regulation Mechanism				Transcription Factor Info
DT Modulation1	Dinitrochlorobenzene results in increased expression of SLC2A3 mRNA			[34]
Regulation Mechanism				Transcription Factor Info
Dinitrofluorobenzene	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Dinitrofluorobenzene increases the expression of SLC2A3			[37]
Pentanal	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Pentanal inhibits the expression of SLC2A3			[45]
DT Modulation1	NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC2A3 mRNA			[48]
Regulation Mechanism				Transcription Factor Info
DT Modulation1	Benzo(a)pyrene affects the methylation of SLC2A3 intron			[65]
Regulation Mechanism				Transcription Factor Info
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	10 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC2A3 protein			[44]
Regulation Mechanism				Transcription Factor Info
DT Modulation2	NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC2A3 mRNA			[48]
Regulation Mechanism				Transcription Factor Info
DT Modulation3	NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC2A3 mRNA			[48]
Regulation Mechanism				Transcription Factor Info
DT Modulation4	NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC2A3 mRNA			[48]
Regulation Mechanism				Transcription Factor Info
DT Modulation5	NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC2A3 mRNA			[48]
Regulation Mechanism				Transcription Factor Info
DT Modulation6	NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC2A3 mRNA			[48]
Regulation Mechanism				Transcription Factor Info
DT Modulation7	NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC2A3 mRNA			[48]
Regulation Mechanism				Transcription Factor Info
DT Modulation8	NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC2A3 mRNA			[48]
Regulation Mechanism				Transcription Factor Info
DT Modulation9	NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC2A3 mRNA			[48]
Regulation Mechanism				Transcription Factor Info
DT Modulation10	NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC2A3 mRNA			[48]
Regulation Mechanism				Transcription Factor Info
4-phenylenediamine	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	4-phenylenediamine results in increased expression of SLC2A3 mRNA			[35]
Regulation Mechanism				Transcription Factor Info
abrine	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	abrine results in decreased expression of SLC2A3 mRNA			[62]
Regulation Mechanism				Transcription Factor Info
Acetylcysteine	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Acetylcysteine inhibits the reaction epigallocatechin gallate results in increased expression of SLC2A3 mRNA			[58]
Regulation Mechanism				Transcription Factor Info
DT Modulation2	Acetylcysteine inhibits the reaction epigallocatechin gallate results in increased expression of SLC2A3 protein			[58]
Regulation Mechanism				Transcription Factor Info
Acetylglucosamine	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Acetylglucosamine results in decreased expression of SLC2A3 mRNA			[64]
Regulation Mechanism				Transcription Factor Info
DT Modulation2	Acetylglucosamine results in increased expression of SLC2A3 mRNA			[64]
Regulation Mechanism				Transcription Factor Info
Aldehydes	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Aldehydes results in decreased expression of SLC2A3 mRNA			[66]
Regulation Mechanism				Transcription Factor Info
amyloid beta-protein (1-40)	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	amyloid beta-protein (1-40) results in decreased expression of SLC2A3 protein			[67]
Regulation Mechanism				Transcription Factor Info
Antimony Potassium Tartrate	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Antimony Potassium Tartrate results in increased abundance of antimonite which results in increased expression of SLC2A3 mRNA			[68]
Regulation Mechanism				Transcription Factor Info
Apigenin	3 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Apigenin co-treated with Oxygen deficiency results in decreased expression of SLC2A3 mRNA			[69]
Regulation Mechanism				Transcription Factor Info
DT Modulation2	Apigenin results in decreased expression of SLC2A3 mRNA			[70]
Regulation Mechanism				Transcription Factor Info
DT Modulation3	Apigenin results in decreased expression of SLC2A3 protein			[70]
Regulation Mechanism				Transcription Factor Info
archazolid B	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	archazolid B results in increased expression of SLC2A3 mRNA			[43]
Regulation Mechanism				Transcription Factor Info
Asbestos, Crocidolite	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Asbestos, Crocidolite results in increased expression of SLC2A3 mRNA			[73]
Regulation Mechanism				Transcription Factor Info
Asbestos, Serpentine	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Asbestos, Serpentine results in increased expression of SLC2A3 mRNA			[74]
Regulation Mechanism				Transcription Factor Info
avobenzone	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	avobenzone results in increased expression of SLC2A3 mRNA			[23]
Regulation Mechanism				Transcription Factor Info
benzo(e)pyrene	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	benzo(e)pyrene results in increased methylation of SLC2A3 intron			[65]
Regulation Mechanism				Transcription Factor Info
beta-lapachone	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	beta-lapachone results in increased expression of SLC2A3 mRNA			[75]
Regulation Mechanism				Transcription Factor Info
bisphenol A	3 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	bisphenol A affects the expression of SLC2A3 mRNA			[56]
Regulation Mechanism				Transcription Factor Info
DT Modulation2	bisphenol A results in decreased methylation of SLC2A3 gene			[76]
Regulation Mechanism				Transcription Factor Info
DT Modulation3	bisphenol A results in increased expression of SLC2A3 mRNA			[77]
Regulation Mechanism				Transcription Factor Info
bruceine D	3 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	bruceine D affects the reaction Oxygen deficiency affects the expression of SLC2A3 protein			[78]
Regulation Mechanism				Transcription Factor Info
DT Modulation2	bruceine D results in decreased expression of SLC2A3 protein			[78]
Regulation Mechanism				Transcription Factor Info
DT Modulation3	CTNNBIP1 protein affects the reaction bruceine D affects the reaction Oxygen deficiency affects the expression of SLC2A3 protein			[78]
Regulation Mechanism				Transcription Factor Info
butyraldehyde	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	butyraldehyde results in decreased expression of SLC2A3 mRNA			[45]
Regulation Mechanism				Transcription Factor Info
Cadmium Chloride	3 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Cadmium Chloride results in decreased expression of SLC2A3 mRNA			[79]
Regulation Mechanism				Transcription Factor Info
DT Modulation2	Cadmium Chloride results in increased expression of SLC2A3 mRNA			[80]
Regulation Mechanism				Transcription Factor Info
DT Modulation3	sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate results in decreased expression of SLC2A3 mRNA			[81]
Regulation Mechanism				Transcription Factor Info
chlorcyclizine	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	chlorcyclizine results in decreased expression of SLC2A3 mRNA			[4]
Regulation Mechanism				Transcription Factor Info
chromic oxide	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate results in decreased expression of SLC2A3 mRNA			[81]
Regulation Mechanism				Transcription Factor Info
chromous chloride	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate results in decreased expression of SLC2A3 mRNA			[81]
Regulation Mechanism				Transcription Factor Info
cobaltous chloride	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	cobaltous chloride results in increased expression of SLC2A3 mRNA			[83]
Regulation Mechanism				Transcription Factor Info
Copper	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Organoselenium Compounds binds to Copper which results in increased expression of SLC2A3 mRNA			[84]
Regulation Mechanism				Transcription Factor Info
Cytochalasin B	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Cytochalasin B inhibits the reaction SLC2A3 protein results in increased transport of Deoxyglucose			[85]
Regulation Mechanism				Transcription Factor Info
Dehydroascorbic Acid	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	SLC2A3 protein affects the transport of Dehydroascorbic Acid			[86]
Regulation Mechanism				Transcription Factor Info
Deoxyglucose	5 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Cytochalasin B inhibits the reaction SLC2A3 protein results in increased transport of Deoxyglucose			[85]
Regulation Mechanism				Transcription Factor Info
DT Modulation2	Galactose inhibits the reaction SLC2A3 protein results in increased transport of Deoxyglucose			[85]
Regulation Mechanism				Transcription Factor Info
DT Modulation3	Glucose inhibits the reaction SLC2A3 protein results in increased transport of Deoxyglucose			[85]
Regulation Mechanism				Transcription Factor Info
DT Modulation4	Maltose inhibits the reaction SLC2A3 protein results in increased transport of Deoxyglucose			[85]
Regulation Mechanism				Transcription Factor Info
DT Modulation5	SLC2A3 protein results in increased transport of Deoxyglucose			[85]
Regulation Mechanism				Transcription Factor Info
diallyl trisulfide	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	diallyl trisulfide results in increased expression of SLC2A3 mRNA			[87]
Regulation Mechanism				Transcription Factor Info
di-n-butylphosphoric acid	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	di-n-butylphosphoric acid affects the expression of SLC2A3 mRNA			[88]
Regulation Mechanism				Transcription Factor Info
dorsomorphin	9 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC2A3 mRNA			[48]
Regulation Mechanism				Transcription Factor Info
DT Modulation2	NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC2A3 mRNA			[48]
Regulation Mechanism				Transcription Factor Info
DT Modulation3	NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC2A3 mRNA			[48]
Regulation Mechanism				Transcription Factor Info
DT Modulation4	NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC2A3 mRNA			[48]
Regulation Mechanism				Transcription Factor Info
DT Modulation5	NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC2A3 mRNA			[48]
Regulation Mechanism				Transcription Factor Info
DT Modulation6	NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC2A3 mRNA			[48]
Regulation Mechanism				Transcription Factor Info
DT Modulation7	NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC2A3 mRNA			[48]
Regulation Mechanism				Transcription Factor Info
DT Modulation8	NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC2A3 mRNA			[48]
Regulation Mechanism				Transcription Factor Info
DT Modulation9	NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC2A3 mRNA			[48]
Regulation Mechanism				Transcription Factor Info
entinostat	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	entinostat results in increased expression of SLC2A3 mRNA			[19]
Regulation Mechanism				Transcription Factor Info
DT Modulation2	NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC2A3 mRNA			[48]
Regulation Mechanism				Transcription Factor Info
epigallocatechin gallate	5 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Acetylcysteine inhibits the reaction epigallocatechin gallate results in increased expression of SLC2A3 mRNA			[58]
Regulation Mechanism				Transcription Factor Info
DT Modulation2	Acetylcysteine inhibits the reaction epigallocatechin gallate results in increased expression of SLC2A3 protein			[58]
Regulation Mechanism				Transcription Factor Info
DT Modulation3	epigallocatechin gallate results in increased expression of SLC2A3 mRNA			[58]
Regulation Mechanism				Transcription Factor Info
DT Modulation4	epigallocatechin gallate results in increased expression of SLC2A3 protein			[58]
Regulation Mechanism				Transcription Factor Info
DT Modulation5	potassium chromate(VI) co-treated with epigallocatechin gallate results in increased expression of SLC2A3 mRNA			[89]
Regulation Mechanism				Transcription Factor Info
fisetin	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	fisetin co-treated with Oxygen deficiency results in decreased expression of SLC2A3 mRNA			[69]
Regulation Mechanism				Transcription Factor Info
Fluorouracil	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	SLC2A3 protein affects the susceptibility to Fluorouracil			[91]
Regulation Mechanism				Transcription Factor Info
Galactose	4 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Galactose inhibits the reaction SLC2A3 protein results in increased transport of Deoxyglucose			[85]
Regulation Mechanism				Transcription Factor Info
DT Modulation2	Glucose inhibits the reaction SLC2A3 protein results in increased transport of Galactose			[85]
Regulation Mechanism				Transcription Factor Info
DT Modulation3	Maltose inhibits the reaction SLC2A3 protein results in increased transport of Galactose			[85]
Regulation Mechanism				Transcription Factor Info
DT Modulation4	SLC2A3 protein results in increased transport of Galactose			[85]
Regulation Mechanism				Transcription Factor Info
Glucose	4 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Glucose inhibits the reaction SLC2A3 protein results in increased transport of Deoxyglucose			[85]
Regulation Mechanism				Transcription Factor Info
DT Modulation2	Glucose inhibits the reaction SLC2A3 protein results in increased transport of Galactose			[85]
Regulation Mechanism				Transcription Factor Info
DT Modulation3	INS protein co-treated with Glucose results in decreased expression of SLC2A3 protein			[92]
Regulation Mechanism				Transcription Factor Info
DT Modulation4	Kynurenic Acid inhibits the reaction INS protein co-treated with Glucose results in decreased expression of SLC2A3 protein			[92]
Regulation Mechanism				Transcription Factor Info
K 7174	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	K 7174 results in decreased expression of SLC2A3 mRNA			[42]
Regulation Mechanism				Transcription Factor Info
Kynurenic Acid	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Kynurenic Acid inhibits the reaction INS protein co-treated with Glucose results in decreased expression of SLC2A3 protein			[92]
Regulation Mechanism				Transcription Factor Info
Lactic Acid	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Lactic Acid affects the expression of SLC2A3 mRNA			[55]
Regulation Mechanism				Transcription Factor Info
lead acetate	5 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	lead acetate results in increased abundance of Lead which results in decreased expression of SLC2A3 mRNA			[93]
Regulation Mechanism				Transcription Factor Info
DT Modulation2	lead acetate results in increased abundance of Lead which results in decreased expression of SLC2A3 protein			[93]
Regulation Mechanism				Transcription Factor Info
DT Modulation3	PPIF protein affects the reaction lead acetate results in increased abundance of Lead which results in decreased expression of SLC2A3 mRNA			[93]
Regulation Mechanism				Transcription Factor Info
DT Modulation4	PPIF protein affects the reaction lead acetate results in increased abundance of Lead which results in decreased expression of SLC2A3 protein			[93]
Regulation Mechanism				Transcription Factor Info
DT Modulation5	sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate results in decreased expression of SLC2A3 mRNA			[81]
Regulation Mechanism				Transcription Factor Info
Luteolin	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Luteolin co-treated with Oxygen deficiency results in decreased expression of SLC2A3 mRNA			[69]
Regulation Mechanism				Transcription Factor Info
Maltose	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Maltose inhibits the reaction SLC2A3 protein results in increased transport of Deoxyglucose			[85]
Regulation Mechanism				Transcription Factor Info
DT Modulation2	Maltose inhibits the reaction SLC2A3 protein results in increased transport of Galactose			[85]
Regulation Mechanism				Transcription Factor Info
Manganese	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	manganese chloride results in increased abundance of Manganese which results in increased expression of SLC2A3 mRNA			[72]
Regulation Mechanism				Transcription Factor Info
DT Modulation2	sodium arsenite results in increased abundance of Arsenic co-treated with manganese chloride results in increased abundance of Manganese results in increased expression of SLC2A3 mRNA			[72]
Regulation Mechanism				Transcription Factor Info
manganese chloride	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	manganese chloride results in increased abundance of Manganese which results in increased expression of SLC2A3 mRNA			[72]
Regulation Mechanism				Transcription Factor Info
DT Modulation2	sodium arsenite results in increased abundance of Arsenic co-treated with manganese chloride results in increased abundance of Manganese results in increased expression of SLC2A3 mRNA			[72]
Regulation Mechanism				Transcription Factor Info
mercuric bromide	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	mercuric bromide results in increased expression of SLC2A3 mRNA			[19]
Regulation Mechanism				Transcription Factor Info
DT Modulation2	NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC2A3 mRNA			[48]
Regulation Mechanism				Transcription Factor Info
Methapyrilene	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Methapyrilene results in increased methylation of SLC2A3 intron			[65]
Regulation Mechanism				Transcription Factor Info
methylmercuric chloride	3 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	methylmercuric chloride results in decreased expression of SLC2A3 mRNA			[94]
Regulation Mechanism				Transcription Factor Info
DT Modulation2	methylmercuric chloride results in increased expression of SLC2A3 mRNA			[94]
Regulation Mechanism				Transcription Factor Info
DT Modulation3	NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC2A3 mRNA			[48]
Regulation Mechanism				Transcription Factor Info
NCS 382	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	NCS 382 results in decreased expression of SLC2A3 mRNA			[95]
Regulation Mechanism				Transcription Factor Info
nickel chloride	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	nickel chloride results in increased expression of SLC2A3 mRNA			[33]
Regulation Mechanism				Transcription Factor Info
nickel sulfate	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	nickel sulfate results in increased expression of SLC2A3 mRNA			[97]
Regulation Mechanism				Transcription Factor Info
nimbolide	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	nimbolide results in decreased expression of SLC2A3 mRNA			[99]
Regulation Mechanism				Transcription Factor Info
NVP-BKM120	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	sotorasib co-treated with trametinib co-treated with NVP-BKM120 results in decreased expression of SLC2A3 mRNA			[100]
Regulation Mechanism				Transcription Factor Info
Oxazolone	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Oxazolone results in increased expression of SLC2A3 mRNA			[34]
Regulation Mechanism				Transcription Factor Info
Oxygen	10 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Apigenin co-treated with Oxygen deficiency results in decreased expression of SLC2A3 mRNA			[69]
Regulation Mechanism				Transcription Factor Info
DT Modulation2	bruceine D affects the reaction Oxygen deficiency affects the expression of SLC2A3 protein			[78]
Regulation Mechanism				Transcription Factor Info
DT Modulation3	CTNNBIP1 protein affects the reaction bruceine D affects the reaction Oxygen deficiency affects the expression of SLC2A3 protein			[78]
Regulation Mechanism				Transcription Factor Info
DT Modulation4	fisetin co-treated with Oxygen deficiency results in decreased expression of SLC2A3 mRNA			[69]
Regulation Mechanism				Transcription Factor Info
DT Modulation5	HIF1A protein affects the reaction Oxygen deficiency results in increased expression of SLC2A3 protein			[101]
Regulation Mechanism				Transcription Factor Info
DT Modulation6	Luteolin co-treated with Oxygen deficiency results in decreased expression of SLC2A3 mRNA			[69]
Regulation Mechanism				Transcription Factor Info
DT Modulation7	Oxygen deficiency affects the expression of SLC2A3 protein			[78]
Regulation Mechanism				Transcription Factor Info
DT Modulation8	Oxygen deficiency results in increased expression of SLC2A3 mRNA			[102]
Regulation Mechanism				Transcription Factor Info
DT Modulation9	Oxygen deficiency results in increased expression of SLC2A3 protein			[101]
Regulation Mechanism				Transcription Factor Info
DT Modulation10	ST6GAL1 protein promotes the reaction Oxygen deficiency results in increased expression of SLC2A3 mRNA			[103]
Regulation Mechanism				Transcription Factor Info
Palmitic Acid	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Palmitic Acid results in increased expression of SLC2A3 mRNA			[104]
Regulation Mechanism				Transcription Factor Info
p-Chloromercuribenzoic Acid	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC2A3 mRNA			[48]
Regulation Mechanism				Transcription Factor Info
DT Modulation2	p-Chloromercuribenzoic Acid results in increased expression of SLC2A3 mRNA			[19]
Regulation Mechanism				Transcription Factor Info
PCI 5002	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	PCI 5002 co-treated with Zinc results in increased expression of SLC2A3 mRNA			[105]
Regulation Mechanism				Transcription Factor Info
pentanal	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	pentanal results in decreased expression of SLC2A3 mRNA			[45]
Regulation Mechanism				Transcription Factor Info
perfluorooctanoic acid	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	perfluorooctanoic acid results in decreased expression of SLC2A3 protein			[106]
Regulation Mechanism				Transcription Factor Info
Perhexiline	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Perhexiline results in decreased expression of SLC2A3 mRNA			[4]
Regulation Mechanism				Transcription Factor Info
DT Modulation2	Perhexiline results in increased expression of SLC2A3 mRNA			[8]
Regulation Mechanism				Transcription Factor Info
PF-06840003	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	PF-06840003 inhibits the reaction MAPT protein mutant form results in decreased expression of SLC2A3 mRNA			[107]
Regulation Mechanism				Transcription Factor Info
Pioglitazone	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Pioglitazone co-treated with tert-Butylhydroperoxide results in increased expression of SLC2A3 mRNA			[108]
Regulation Mechanism				Transcription Factor Info
potassium chromate(VI)	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	potassium chromate(VI) co-treated with epigallocatechin gallate results in increased expression of SLC2A3 mRNA			[89]
Regulation Mechanism				Transcription Factor Info
DT Modulation2	potassium chromate(VI) results in increased expression of SLC2A3 mRNA			[89]
Regulation Mechanism				Transcription Factor Info
resorcinol	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	resorcinol results in increased expression of SLC2A3 mRNA			[39]
Regulation Mechanism				Transcription Factor Info
Rosiglitazone	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Rosiglitazone co-treated with tert-Butylhydroperoxide results in increased expression of SLC2A3 mRNA			[108]
Regulation Mechanism				Transcription Factor Info
DT Modulation2	Rosiglitazone inhibits the reaction tert-Butylhydroperoxide results in increased expression of SLC2A3 mRNA			[108]
Regulation Mechanism				Transcription Factor Info
S-(1,2-dichlorovinyl)cysteine	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides results in decreased expression of SLC2A3 mRNA			[110]
Regulation Mechanism				Transcription Factor Info
Silicon Dioxide	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Silicon Dioxide results in decreased expression of SLC2A3 mRNA			[111]
Regulation Mechanism				Transcription Factor Info
DT Modulation2	Silicon Dioxide results in increased expression of SLC2A3 mRNA			[73]
Regulation Mechanism				Transcription Factor Info
sodium arsenate	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	sodium arsenate results in increased abundance of Arsenic which results in increased expression of SLC2A3 mRNA			[71]
Regulation Mechanism				Transcription Factor Info
sodium arsenite	5 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate results in decreased expression of SLC2A3 mRNA			[81]
Regulation Mechanism				Transcription Factor Info
DT Modulation2	sodium arsenite results in decreased expression of SLC2A3 mRNA			[81]
Regulation Mechanism				Transcription Factor Info
DT Modulation3	sodium arsenite results in increased abundance of Arsenic co-treated with manganese chloride results in increased abundance of Manganese results in increased expression of SLC2A3 mRNA			[72]
Regulation Mechanism				Transcription Factor Info
DT Modulation4	sodium arsenite results in increased abundance of Arsenic which results in increased expression of SLC2A3 mRNA			[72]
Regulation Mechanism				Transcription Factor Info
DT Modulation5	sodium arsenite results in increased expression of SLC2A3 mRNA			[112]
Regulation Mechanism				Transcription Factor Info
sotorasib	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	sotorasib co-treated with trametinib co-treated with NVP-BKM120 results in decreased expression of SLC2A3 mRNA			[100]
Regulation Mechanism				Transcription Factor Info
sulforaphane	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	sulforaphane results in increased expression of SLC2A3 mRNA			[47]
Regulation Mechanism				Transcription Factor Info
tert-Butylhydroperoxide	6 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Pioglitazone co-treated with tert-Butylhydroperoxide results in increased expression of SLC2A3 mRNA			[108]
Regulation Mechanism				Transcription Factor Info
DT Modulation2	Rosiglitazone co-treated with tert-Butylhydroperoxide results in increased expression of SLC2A3 mRNA			[108]
Regulation Mechanism				Transcription Factor Info
DT Modulation3	Rosiglitazone inhibits the reaction tert-Butylhydroperoxide results in increased expression of SLC2A3 mRNA			[108]
Regulation Mechanism				Transcription Factor Info
DT Modulation4	tert-Butylhydroperoxide results in increased expression of SLC2A3 mRNA			[108]
Regulation Mechanism				Transcription Factor Info
DT Modulation5	Troglitazone co-treated with tert-Butylhydroperoxide results in increased expression of SLC2A3 mRNA			[108]
Regulation Mechanism				Transcription Factor Info
DT Modulation6	Troglitazone inhibits the reaction tert-Butylhydroperoxide results in increased expression of SLC2A3 mRNA			[108]
Regulation Mechanism				Transcription Factor Info
Tetrachlorodibenzodioxin	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Tetrachlorodibenzodioxin results in decreased expression of SLC2A3 mRNA			[113]
Regulation Mechanism				Transcription Factor Info
trametinib	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	sotorasib co-treated with trametinib co-treated with NVP-BKM120 results in decreased expression of SLC2A3 mRNA			[100]
Regulation Mechanism				Transcription Factor Info
tributyltin	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	tributyltin results in decreased expression of SLC2A3 mRNA			[35]
Regulation Mechanism				Transcription Factor Info
trichostatin A	3 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC2A3 mRNA			[48]
Regulation Mechanism				Transcription Factor Info
DT Modulation2	trichostatin A affects the expression of SLC2A3 mRNA			[115]
Regulation Mechanism				Transcription Factor Info
DT Modulation3	trichostatin A results in increased expression of SLC2A3 mRNA			[116]
Regulation Mechanism				Transcription Factor Info
triphenyl phosphate	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	triphenyl phosphate affects the expression of SLC2A3 mRNA			[88]
Regulation Mechanism				Transcription Factor Info
Troglitazone	2 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Troglitazone co-treated with tert-Butylhydroperoxide results in increased expression of SLC2A3 mRNA			[108]
Regulation Mechanism				Transcription Factor Info
DT Modulation2	Troglitazone inhibits the reaction tert-Butylhydroperoxide results in increased expression of SLC2A3 mRNA			[108]
Regulation Mechanism				Transcription Factor Info
uranyl acetate	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	uranyl acetate affects the expression of SLC2A3 mRNA			[32]
Regulation Mechanism				Transcription Factor Info
Vanadates	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	Vanadates results in increased expression of SLC2A3 mRNA			[117]
Regulation Mechanism				Transcription Factor Info
vanadium pentoxide	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	vanadium pentoxide affects the expression of SLC2A3 mRNA			[118]
Regulation Mechanism				Transcription Factor Info
vandetanib	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	vandetanib results in increased expression of SLC2A3 mRNA			[5]
Regulation Mechanism				Transcription Factor Info
warangalone	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	warangalone analog results in decreased expression of SLC2A3 protein			[119]
Regulation Mechanism				Transcription Factor Info
Zinc	1 DT Activity Modulations Related to This Exogenous Factor		Click to Show/Hide the Full List
DT Modulation1	PCI 5002 co-treated with Zinc results in increased expression of SLC2A3 mRNA			[105]
Regulation Mechanism				Transcription Factor Info

References
1	GLUT3 upregulation promotes metabolic reprogramming associated with antiangiogenic therapy resistance. JCI Insight. 2017 Jan 26;2(2):e88815.
2	Yin Yang 1 promotes the Warburg effect and tumorigenesis via glucose transporter GLUT3. Cancer Sci. 2018 Aug;109(8):2423-2434.
3	Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta. Mol Biol Cell. 2004 Mar;15(3):1262-72.
4	A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system. Toxicol Sci. 2005 Feb;83(2):282-92.
5	ZD6474 inhibits tumor growth and intraperitoneal dissemination in a highly metastatic orthotopic gastric cancer model. Int J Cancer. 2006 Jan 15;118(2):483-9.
6	Retinoic acid represses a cassette of candidate pluripotency chromosome 12p genes during induced loss of human embryonal carcinoma tumorigenicity. Biochim Biophys Acta. 2005 Oct 15;1731(1):48-56.
7	Gene expression profiling of breast cancer cells in response to gemcitabine: NF-kappaB pathway activation as a potential mechanism of resistance. Breast Cancer Res Treat. 2007 Apr;102(2):157-72.
8	Determination of phospholipidosis potential based on gene expression analysis in HepG2 cells. Toxicol Sci. 2007 Mar;96(1):101-14.
9	In vitro detection of drug-induced phospholipidosis using gene expression and fluorescent phospholipid based methodologies. Toxicol Sci. 2007 Sep;99(1):162-73.
10	The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxide. Exp Hematol. 2011 Jan;39(1):55-65.
11	Effects of 1alpha,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol Cancer. 2011 May 18;10:58.
12	Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011 Sep;26(5):593-604.
13	Growth inhibition of ovarian tumor-initiating cells by niclosamide. Mol Cancer Ther. 2012 Aug;11(8):1703-12.
14	Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.
15	Differential gene expression in human hepatocyte cell lines exposed to the antiretroviral agent zidovudine. Arch Toxicol. 2014 Mar;88(3):609-23.
16	Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium. Arthritis Rheumatol. 2014 Jan;66(1):15-23.
17	Dose-dependent effects of caffeine in human Sertoli cells metabolism and oxidative profile: relevance for male fertility. Toxicology. 2015 Feb 3;328:12-20.
18	Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20.
19	A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.
20	Low Doses of Cisplatin Induce Gene Alterations, Cell Cycle Arrest, and Apoptosis in Human Promyelocytic Leukemia Cells. Biomark Insights. 2016 Aug 24;11:113-21.
21	Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
22	Bringing in vitro analysis closer to in vivo: Studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
23	A long-wave UVA filter avobenzone induces obesogenic phenotypes in normal human epidermal keratinocytes and mesenchymal stem cells. Arch Toxicol. 2019 Jul;93(7):1903-1915.
24	Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1. Redox Biol. 2020 Jan;28:101321.
25	Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761.
26	Capturing time-dependent activation of genes and stress-response pathways using transcriptomics in iPSC-derived renal proximal tubule cells. Cell Biol Toxicol. 2022 Dec 31.
27	Hepatic cells derived from human skin progenitors show a typical phospholipidotic response upon exposure to amiodarone. Toxicol Lett. 2018 Mar 1;284:184-194.
28	Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
29	Endoplasmic reticulum stress contributes to arsenic trioxide-induced intrinsic apoptosis in human umbilical and bone marrow mesenchymal stem cells. Environ Toxicol. 2016 Mar;31(3):314-28.
30	Stem Cell Transcriptome Responses and Corresponding Biomarkers That Indicate the Transition from Adaptive Responses to Cytotoxicity. Chem Res Toxicol. 2017 Apr 17;30(4):905-922.
31	Akt and cAMP response element binding protein mediate 17beta-estradiol regulation of glucose transporter 3 expression in human SH-SY5Y neuroblastoma cell line. Neurosci Lett. 2015 Sep 14;604:58-63.
32	Transcriptomic and proteomic responses of human renal HEK293 cells to uranium toxicity. Proteomics. 2005 Jan;5(1):297-306.
33	The contact allergen nickel triggers a unique inflammatory and proangiogenic gene expression pattern via activation of NF-kappaB and hypoxia-inducible factor-1alpha. J Immunol. 2007 Mar 1;178(5):3198-207.
34	Microarray analyses in dendritic cells reveal potential biomarkers for chemical-induced skin sensitization. Mol Immunol. 2007 May;44(12):3222-33.
35	THP-1 monocytes but not macrophages as a potential alternative for CD34+ dendritic cells to identify chemical skin sensitizers. Toxicol Appl Pharmacol. 2009 Apr 15;236(2):221-30.
36	Microarray analysis of gene expression patterns in human proximal tubule cells over a short and long time course of cadmium exposure. J Toxicol Environ Health A. 2011;74(1):24-42.
37	Functionality and specificity of gene markers for skin sensitization in dendritic cells. Toxicol Lett. 2011 Jun 10;203(2):106-10.
38	Fine particulate matter from urban ambient and wildfire sources from California's San Joaquin Valley initiate differential inflammatory, oxidative stress, and xenobiotic responses in human bronchial epithelial cells. Toxicol In Vitro. 2011 Dec;25(8):1895-905.
39	A transcriptomics-based in vitro assay for predicting chemical genotoxicity in vivo. Carcinogenesis. 2012 Jul;33(7):1421-9.
40	Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells. J Biol Chem. 2012 Dec 14;287(51):43137-55.
41	Clarifying off-target effects for torcetrapib using network pharmacology and reverse docking approach. BMC Syst Biol. 2012 Dec 10;6:152.
42	A low-molecular-weight compound K7174 represses hepcidin: possible therapeutic strategy against anemia of chronic disease. PLoS One. 2013 Sep 27;8(9):e75568.
43	Up-regulation of cholesterol associated genes as novel resistance mechanism in glioblastoma cells in response to archazolid B. Toxicol Appl Pharmacol. 2014 Nov 15;281(1):78-86.
44	Activin/nodal signaling switches the terminal fate of human embryonic stem cell-derived trophoblasts. J Biol Chem. 2015 Apr 3;290(14):8834-48.
45	Integrated analysis of microRNA and mRNA expression profiles highlights aldehyde-induced inflammatory responses in cells relevant for lung toxicity. Toxicology. 2015 Aug 6;334:111-21.
46	Defensive and adverse energy-related molecular responses precede tris (1, 3-dichloro-2-propyl) phosphate cytotoxicity. J Appl Toxicol. 2016 May;36(5):649-58.
47	Sulforaphane-induced apoptosis in human leukemia HL-60 cells through extrinsic and intrinsic signal pathways and altering associated genes expression assayed by cDNA microarray. Environ Toxicol. 2017 Jan;32(1):311-328.
48	Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests. Arch Toxicol. 2017 Feb;91(2):839-864.
49	Cystathionine metabolic enzymes play a role in the inflammation resolution of human keratinocytes in response to sub-cytotoxic formaldehyde exposure. Toxicol Appl Pharmacol. 2016 Nov 1;310:185-194.
50	Inhibition of histone H3K27 demethylases selectively modulates inflammatory phenotypes of natural killer cells. J Biol Chem. 2018 Feb 16;293(7):2422-2437.
51	LSD1 activates a lethal prostate cancer gene network independently of its demethylase function. Proc Natl Acad Sci U S A. 2018 May 1;115(18):E4179-E4188.
52	RNA-sequencing reveals long-term effects of silver nanoparticles on human lung cells. Sci Rep. 2018 Apr 27;8(1):6668.
53	Transcriptome and DNA Methylome Dynamics during Triclosan-Induced Cardiomyocyte Differentiation Toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
54	Marine biogenics in sea spray aerosols interact with the mTOR signaling pathway. Sci Rep. 2019 Jan 24;9(1):675.
55	Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.
56	Comprehensive analysis of transcriptomic changes induced by low and high doses of bisphenol A in HepG2 spheroids in vitro and rat liver in vivo. Environ Res. 2019 Jun;173:124-134.
57	Di-(2-ethylhexyl)-phthalate induces apoptosis via the PPAR Gamma/PTEN/AKT pathway in differentiated human embryonic stem cells. Food Chem Toxicol. 2019 Sep;131:110552.
58	Epigallocatechin-3-gallate downregulates PDHA1 interfering the metabolic pathways in human herpesvirus 8 harboring primary effusion lymphoma cells. Toxicol In Vitro. 2020 Jun;65:104753.
59	Integration of transcriptome analysis with pathophysiological endpoints to evaluate cigarette smoke toxicity in an in vitro human airway tissue model. Arch Toxicol. 2021 May;95(5):1739-1761.
60	Cellular and Molecular Effects of Prolonged Low-Level Sodium Arsenite Exposure on Human Hepatic HepaRG Cells. Toxicol Sci. 2018 Apr 1;162(2):676-687.
61	New insights into BaP-induced toxicity: role of major metabolites in transcriptomics and contribution to hepatocarcinogenesis. Arch Toxicol. 2016 Jun;90(6):1449-58.
62	Integration of transcriptomics, proteomics and metabolomics data to reveal the biological mechanisms of abrin injury in human lung epithelial cells. Toxicol Lett. 2019;312:1-10.
63	Gene expression analysis of precision-cut human liver slices indicates stable expression of ADME-Tox related genes. Toxicol Appl Pharmacol. 2011 May 15;253(1):57-69.
64	Genomic expression changes induced by topical N-acetyl glucosamine in skin equivalent cultures in vitro. J Cosmet Dermatol. 2007;6(4):232-8.
65	Effect of aflatoxin B(1), benzo[a]pyrene, and methapyrilene on transcriptomic and epigenetic alterations in human liver HepaRG cells. Food Chem Toxicol. 2018;121:214-223.
66	Transcriptome profile analysis of saturated aliphatic aldehydes reveals carbon number-specific molecules involved in pulmonary toxicity. Chem Res Toxicol. 2014 Aug 18;27(8):1362-70.
67	Abeta peptides disrupt the barrier integrity and glucose metabolism of human induced pluripotent stem cell-derived brain microvascular endothelial cells. Neurotoxicology. 2022;89:110-120.
68	Deducing signaling pathways from parallel actions of arsenite and antimonite in human epidermal keratinocytes. Sci Rep. 2020;10(1):2890.
69	Flavonoids inhibit hypoxia-induced vascular endothelial growth factor expression by a HIF-1 independent mechanism. Biochem Pharmacol. 2010;79(11):1600-9.
70	The effect of Apigenin on glycometabolism and cell death in an anaplastic thyroid cancer cell line. Toxicol Appl Pharmacol. 2023;475:116626.
71	Effects of Inorganic Arsenic on Human Prostate Stem-Progenitor Cell Transformation, Autophagic Flux Blockade, and NRF2 Pathway Activation. Environ Health Perspect. 2020;128(6):67008.
72	Using transcriptomic signatures to elucidate individual and mixture effects of inorganic arsenic and manganese in human placental trophoblast HTR-8/SVneo cells. Toxicol Sci. 2025;203(2):216-226.
73	Indications for distinct pathogenic mechanisms of asbestos and silica through gene expression profiling of the response of lung epithelial cells. Hum Mol Genet. 2015;24(5):1374-89.
74	DNA methylation profiling of asbestos-treated MeT5A cell line reveals novel pathways implicated in asbestos response. Arch Toxicol. 2018;92(5):1785-1795.
75	Lapachone induces ferroptosis of colorectal cancer cells via NCOA4-mediated ferritinophagy by activating JNK pathway. Chem Biol Interact. 2024;389:110866.
76	DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019;11(1):138.
77	BPA exposure enhances the metastatic aggression of ovarian cancer through the ER/AKT/mTOR/HIF-1 signaling axis. Food Chem Toxicol. 2023;176:113792.
78	Bruceine D inhibits HIF-1-mediated glucose metabolism in hepatocellular carcinoma by blocking ICAT/-catenin interaction. Acta Pharm Sin B. 2021;11(11):3481-3492.
79	Gene expression and pathway analysis of human hepatocellular carcinoma cells treated with cadmium. Toxicol Appl Pharmacol. 2015;288(3):399-408.
80	Evaluation of Cd-induced cytotoxicity in primary human keratinocytes. Hum Exp Toxicol. 2024;43:9603271231224458.
81	Characterization of gene expression changes associated with MNNG, arsenic, or metal mixture treatment in human keratinocytes: application of cDNA microarray technology. Environ Health Perspect. 2002;110 Suppl 6(Suppl 6):931-41.
82	Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. Toxicol Appl Pharmacol. 2022;449:116110.
83	Transcription and splicing regulation in human umbilical vein endothelial cells under hypoxic stress conditions by exon array. BMC Genomics. 2009;10:126.
84	A selenosemicarbazone complex with copper efficiently down-regulates the 90-kDa heat shock protein HSP90AA1 and its client proteins in cancer cells. BMC Cancer. 2014;14:629.
85	Kinetic analysis of the liver-type (GLUT2) and brain-type (GLUT3) glucose transporters in Xenopus oocytes: substrate specificities and effects of transport inhibitors. Biochem J. 1993;290 ( Pt 3)(Pt 3):701-6.
86	6-Bromo-6-deoxy-L-ascorbic acid: an ascorbate analog specific for Na+-dependent vitamin C transporter but not glucose transporter pathways. J Biol Chem. 2005;280(7):5211-20.
87	In vitro anti-synovial sarcoma effect of diallyl trisulfide and mRNA profiling. Gene. 2022;816:146172.
88	Association between Organophosphate Ester Exposure and Insulin Resistance with Glycometabolic Disorders among Older Chinese Adults 60-69 Years of Age: Evidence from the China BAPE Study. Environ Health Perspect. 2023;131(4):47009.
89	Epigallocatechin-3-gallate (EGCG) protects against chromate-induced toxicity in vitro. Toxicol Appl Pharmacol. 2012 Jan 15;258(2):166-75.
90	Transforming growth factor beta1 targets estrogen receptor signaling in bronchial epithelial cells. Respir Res. 2018 Aug 30;19(1):160.
91	Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations. Int J Cancer. 2006;118(7):1699-712.
92	N-Methyl-D aspartate receptor-mediated effect on glucose transporter-3 levels of high glucose exposed-SH-SY5Y dopaminergic neurons. Food Chem Toxicol. 2017;109(Pt 1):465-471.
93	CypD deficiency confers neuroprotection against mitochondrial abnormality caused by lead in SH-SY5Y cell. Toxicol Lett. 2020;323:25-34.
94	Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
95	In vitro toxicological evaluation of NCS-382, a high-affinity antagonist of hydroxybutyrate (GHB) binding. Toxicol In Vitro. 2017;40:196-202.
96	Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response. J Allergy Clin Immunol. 2014;134(2):362-72.
97	Gene expression signatures in CD34+-progenitor-derived dendritic cells exposed to the chemical contact allergen nickel sulfate. Toxicol Appl Pharmacol. 2006;216(1):131-49.
98	Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma. Cancer Res. 2023;83(2):181-194.
99	Nimbolide induces cell death in T lymphoma cells: Implication of altered apoptosis and glucose metabolism. Environ Toxicol. 2021;36(4):628-641.
100	Inhibition of KRAS, MEK and PI3K Demonstrate Synergistic Anti-Tumor Effects in Pancreatic Ductal Adenocarcinoma Cell Lines. Cancers (Basel). 2022;14(18).
101	Hypoxic upregulation of glucose transporters in BeWo choriocarcinoma cells is mediated by hypoxia-inducible factor-1. Am J Physiol Cell Physiol. 2007 Jul;293(1):C477-85.
102	Hypoxia activates the cyclooxygenase-2-prostaglandin E synthase axis. Carcinogenesis. 2010;31(3):427-34.
103	The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1 signaling. J Biol Chem. 2018;293(15):5659-5667.
104	Palmitic Acid Induced a Dedifferentiation Profile at the Transcriptome Level: A Collagen Synthesis but no Triglyceride Accumulation in Hepatocyte-Like Cells Derived From Human-Induced Pluripotent Stem Cells Cultivated Inside Organ on a Chip. J Appl Toxicol. 2025;45(3):460-471.
105	Synthesis and anticancer properties of water-soluble zinc ionophores. Cancer Res. 2008 Jul 1;68(13):5318-25.
106	High perfluorooctanoic acid exposure induces autophagy blockage and disturbs intracellular vesicle fusion in the liver. Arch Toxicol. 2017;91(1):247-258.
107	Restoring hippocampal glucose metabolism rescues cognition across Alzheimer's disease pathologies. Science. 2024;385(6711):eabm6131.
108	Differential effects of PPARgamma ligands on oxidative stress-induced death of retinal pigmented epithelial cells. Invest Ophthalmol Vis Sci. 2011;52(2):890-903.
109	Proteomic analysis of human iPSC-derived sympathetic neurons identifies proteostasis collapse as a molecular signature following subtoxic rotenone exposure. Toxicology. 2025;510:154015.
110	The trichloroethylene metabolite S-(1,2-dichlorovinyl)-l-cysteine inhibits lipopolysaccharide-induced inflammation transcriptomic pathways and cytokine secretion in a macrophage cell model. Toxicol In Vitro. 2022;84:105429.
111	Profiling of the silica-induced molecular events in lung epithelial cells using the RNA-Seq approach. J Appl Toxicol. 2017;37(10):1162-1173.
112	Dynamic alteration in miRNA and mRNA expression profiles at different stages of chronic arsenic exposure-induced carcinogenesis in a human cell culture model of skin cancer. Arch Toxicol. 2021 Jul;95(7):2351-2365.
113	Identification of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-inducible genes in human amniotic epithelial cells. Reprod Biol Endocrinol. 2006;4:27.
114	Retinoic acid-induced downmodulation of telomerase activity in human cancer cells. Exp Mol Pathol. 2005 Oct;79(2):108-17.
115	A trichostatin A expression signature identified by TempO-Seq targeted whole transcriptome profiling. PLoS One. 2017 May 25;12(5):e0178302.
116	From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. Arch Toxicol. 2014 Jul;88(7):1451-68.
117	Gene expression changes in human lung cells exposed to arsenic, chromium, nickel or vanadium indicate the first steps in cancer. Metallomics. 2012 Aug;4(8):784-93.
118	Genomic analysis of human lung fibroblasts exposed to vanadium pentoxide to identify candidate genes for occupational bronchitis. Respir Res. 2007;8(1):34.
119	Final-2 targeted glycolysis mediated apoptosis and autophagy in human lung adenocarcinoma cells but failed to inhibit xenograft in nude mice. Food Chem Toxicol. 2019;130:1-11.

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.

Detail Information of Exogenous Modulation

Visitor Map

Correspondence